Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
Clinical trial NCT02225470 · COMPLETED
Trial details
- NCT number
- NCT02225470
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-26
- Primary completion
- 2017-09-29
- Enrollment
- 530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.